Strafford will be offering a webinar entitled "Sect. 112 Indefiniteness in Chemical and Biotech Patent Claims -- Drafting and Prosecuting Patent Claims That Will Hold Up Under Any Definiteness Standard" on February 14, 2018 from 1:00 to 2:30 pm (EST). Thomas L. Irving and Amanda K. Murphy of Finnegan Henderson Farabow Garrett & Dunner, and Amelia Feulner Baur of McNeill Baur will provide guidance to patent counsel on the impact of recent Federal Circuit and PTAB case law on daily patent practice, and offer best practices to navigate pre- and post-issuance scrutiny for compliance with 35 U.S.C. § 112(b). The webinar will review the following issues:
• How do the decisions distinguish the USPTO’s standard and the court’s standard for indefiniteness?
• What are the implications of the post-Nautilus and post-Packard/McAward cases for patent counsel in drafting applications?
• What steps can counsel take to increase the likelihood that patent claims will survive in litigation and under PTAB review?
The registration fee for the webcast is $297. Those interested in registering for the webinar, can do so here.
Comments